The 10th Annual Johns Hopkins Dystonia & Spasticity Practicum Update: Toxin Treatment in the Managed Care Environment: Precertification, Medical Justification and Formulary is organized by Johns Hopkins Medicine (JHM) and will be held from Apr 28, 2017 - Apr 28, 2019.
The target audience for this medical event is neurology and physical medicine and rehabilitation residents and fellows, as well as community neurologists, physiatrists, physical, and occupational therapists. This CME Conference has been approved for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.
Conference Description :
The cost of botulinum toxins to treat patients with dystonia and spasticity is one of the fastest growing healthcare expenditures. Currently, botulinum toxin therapies are the third most costly prior authorization for payors to manage. This educational activity will provide clinicians a comprehensive update regarding botulin toxin treatments in the managed care environment. Specifically, it will address precertifications and prior authorizations, medical justifications, and formulary decisions, as well as strategies to facilitate access to botulinum toxin therapies.
Conference Goal :
The goal of this activity will be to educate clinicians on strategies to facilitate access to botulinum toxin therapy in the managed care environment.
Conference Objective :
• Describe patient- and provider-specific strategies for facilitating access to botulinum toxin therapy.
Additional details will be posted as soon as they are available.
Neurology, Infectious Disease